MBOTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Microbot Medical Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$0.95+0.00 (+0.29%)

Close on Oct 19, 2026

Market cap: $63.99M
P/E (TTM): –
Dividend yield: –

Microbot Medical Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30	Q1 2017 2017-03-31	Q4 2016 2016-12-31	Q3 2016 2016-09-30	Q2 2016 2016-06-30
Cash & Equivalents	3.15	3.66	3.91	6.70	4.08	3.22	3.11	0.48	2.47	1.16	2.47	1.34	5.72	2.15	2.44	7.29	10	13	13	16	18	20	27	28	30	29	3.55	4.88	5.36	5.24	6.67	8.05	9.49	11	12	13	5.00	2.71	0.57	0.84
Short-Term Investments	64	69	75	73	29	27	2.36	3.86	4.00	5.19	3.92	6.82	4.20	2.91	5.76	2.00	2.00	2.00	5.00	5.00	5.00	5.00	–	–	–	2.52	2.50	2.50	2.50	–	–	–	–	–	–	–	–	–	–	–
Cash & Short-Term Investments	67	73	79	80	33	30	5.47	4.34	6.46	6.35	6.39	8.15	9.92	5.06	8.20	9.29	12	15	18	21	23	25	27	28	30	31	6.05	7.38	7.85	5.24	6.67	8.05	9.49	11	12	13	5.00	2.71	0.57	0.84
Receivables	0.18	0.11	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Inventory	2.91	2.26	0.58	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Prepaid Expenses & Other	0.71	0.66	0.64	0.57	0.16	0.22	0.30	0.61	0.63	0.60	0.15	0.21	0.37	0.48	0.53	0.28	0.20	0.30	0.28	0.26	0.20	0.52	0.33	0.46	0.44	0.29	0.19	0.22	–	0.57	–	–	–	0.08	–	–	0.18	0.19	–	–
Other Current Assets	–	–	–	–	–	–	–	–	–	–	1.34	–	–	–	–	–	–	0.30	–	–	–	0.52	–	–	–	0.29	–	–	1.00	0.57	0.15	0.25	0.19	0.12	–	–	–	0.61	0.00	0.04
Total Current Assets	72	77	80	81	33	31	5.82	5.00	7.14	7.00	7.92	8.41	10	5.58	8.81	9.65	13	16	19	21	23	25	27	29	30	36	10	12	13	5.83	6.85	8.30	9.68	11	12	14	5.61	3.32	2.11	4.84
Property, Plant & Equipment	0.32	0.19	0.09	0.08	0.08	0.08	0.08	0.10	0.12	0.13	0.15	0.18	0.18	0.20	0.22	0.28	0.24	0.24	0.23	0.23	0.24	0.25	0.26	0.27	0.28	0.23	0.22	0.23	0.25	0.26	0.28	0.29	0.21	0.09	0.07	0.07	0.07	0.05	–	–
Gross Property, Plant & Equipment	–	–	0.72	–	–	–	0.66	–	–	–	0.64	–	–	–	0.61	–	–	0.53	–	–	–	0.46	–	–	–	0.37	–	–	–	0.39	–	–	–	0.17	–	–	0.14	0.11	–	–
Accumulated Depreciation	–	–	-0.63	–	–	–	-0.58	–	–	–	-0.49	–	–	–	-0.39	–	–	-0.29	–	–	–	-0.21	–	–	–	-0.15	–	–	–	-0.13	–	–	–	-0.08	–	–	-0.07	-0.06	–	–
Operating Lease Right-of-Use Assets	0.80	0.87	0.83	0.90	0.17	0.16	0.13	0.11	0.17	0.24	0.26	0.30	0.37	0.43	0.50	0.62	0.69	0.64	0.69	0.67	0.73	0.78	0.82	0.87	0.92	0.96	0.42	0.49	0.56	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.04	0.04
Total Assets	73	78	82	82	33	31	6.03	5.21	7.43	7.37	8.33	8.89	11	6.21	9.54	11	14	17	20	22	24	26	28	30	31	37	11	13	14	6.09	7.13	8.59	9.89	11	12	14	5.68	3.37	2.14	6.32
Accounts Payable	0.87	1.09	0.51	0.51	0.50	0.19	0.17	0.25	0.18	0.10	0.36	0.24	0.24	0.22	0.12	0.23	0.21	0.28	0.49	0.35	0.41	0.28	0.19	0.15	0.20	0.28	0.28	0.18	0.12	0.63	0.19	0.19	0.09	0.08	0.02	0.10	0.30	0.51	0.81	4.17
Accrued Expenses	2.69	1.98	2.61	2.13	2.12	1.62	2.23	1.06	1.05	0.90	1.03	1.05	0.86	0.74	1.67	1.20	1.15	1.43	0.64	0.69	0.69	0.88	0.55	0.52	0.55	0.80	0.44	0.45	0.55	0.76	0.36	0.39	0.38	0.45	0.49	0.67	0.52	0.27	0.56	2.34
Current Portion of Leases	0.33	0.32	0.30	0.30	0.10	0.09	0.07	0.07	0.11	0.19	0.19	0.21	0.23	0.27	0.28	0.30	0.32	0.28	0.27	0.17	0.17	0.19	0.18	0.19	0.18	0.14	0.31	0.30	0.31	–	–	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.02	0.02
Other Current Liabilities	–	–	0.01	–	–	–	0.01	–	–	–	0.08	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.61	–	–	–	0.47	–	–	–	0.33	–	–	0.39	0.15	–	–
Total Current Liabilities	3.89	3.39	3.42	2.93	2.73	1.89	2.46	1.37	1.34	1.18	3.79	1.49	1.32	1.23	2.07	1.72	1.68	1.98	1.40	1.20	1.28	1.35	0.92	0.85	0.93	4.83	4.59	4.41	4.43	4.76	0.56	0.58	0.47	0.53	0.51	0.77	0.82	0.78	3.47	10
Long-Term Leases	0.55	0.57	0.57	0.60	0.05	0.05	0.04	0.03	0.04	0.02	0.04	0.04	0.09	0.13	0.18	0.28	0.39	0.40	0.44	0.54	0.57	0.63	0.63	0.67	0.69	0.76	0.13	0.19	0.25	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	0.88	0.90	0.87	0.90	0.15	0.14	0.11	0.09	0.15	0.21	0.23	0.25	0.32	0.39	0.46	0.57	0.70	0.68	0.70	0.71	0.74	0.81	0.81	0.86	0.87	0.90	0.45	0.49	0.56	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.13	0.13
Total Liabilities	4.44	3.96	3.99	3.54	2.77	1.94	2.50	1.40	1.38	1.20	3.83	1.53	1.42	1.36	2.25	2.00	2.06	2.39	1.83	1.75	1.84	1.97	1.55	1.52	1.62	5.59	4.72	4.59	4.68	4.76	0.56	0.59	0.48	0.56	0.55	0.81	1.29	1.17	4.27	11
Common Stock	0.67	0.67	0.67	0.66	0.38	0.35	0.20	0.17	0.16	0.15	0.12	0.12	0.12	0.08	0.08	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.04	0.04	0.04	0.03	0.03	0.44	0.42	0.03	0.37	0.34	0.27	0.27	0.16	0.12
Additional Paid-In Capital	182	181	181	178	127	122	94	91	90	88	84	84	83	76	76	71	70	70	70	69	69	69	68	67	67	70	43	43	42	33	32	31	31	31	30	30	18	14	466	459
Retained Earnings	-113	-108	-104	-101	-97	-94	-91	-88	-84	-82	-80	-76	-74	-72	-69	-62	-59	-56	-52	-49	-47	-44	-42	-39	-37	-35	-33	-31	-30	-28	-26	-24	-22	-21	-19	-18	-14	-13	-468	-464
Treasury Stock	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-3.38	-3.38	-3.38	-3.38	-3.38	-0.50	-0.50	-0.50	-0.50	-0.50	-500	-0.50	–	–	–
Comprehensive Income & Other	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.05	0.05
Shareholders' Equity	69	74	78	78	30	29	3.53	3.81	6.06	6.17	4.50	7.36	9.47	4.85	7.29	8.54	12	14	18	20	22	24	26	28	30	32	6.40	7.98	9.23	1.33	6.07	7.51	8.93	9.99	11	12	3.89	1.70	-2.12	-4.89
Total Equity	69	74	78	78	30	29	3.53	3.81	6.06	6.17	4.50	7.36	9.47	4.85	7.29	8.54	12	14	18	20	22	24	26	28	30	32	6.40	7.98	9.23	1.33	6.07	7.51	8.93	9.99	11	12	3.89	1.70	-2.12	-4.89
Total Liabilities & Equity	73	78	82	82	33	31	6.03	5.21	7.43	7.37	8.33	8.89	11	6.21	9.54	11	14	17	20	22	24	26	28	30	31	37	11	13	14	6.09	7.13	8.59	9.89	11	12	14	5.68	3.37	2.14	6.32
Shares Outstanding(shares)	67	67	67	66	38	35	19	17	16	14	12	12	12	8.13	7.89	7.11	7.11	7.11	7.11	7.11	7.11	7.11	7.11	7.10	7.10	7.19	4.31	4.31	4.31	3.01	2.25	2.24	2.13	2.01	1.78	1.60	1.12	1.07	1.10	0.80

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -32.4%

Financial strength

Current ratio: 18.56
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 81.1%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 0.93
Dividend yield: –